Report
Rune Majlund Dahl
EUR 423.80 For Business Accounts Only

Handicare (Buy, TP: SEK46.00) - Signs of Patient Handling progress

We expect a pick-up in organic growth in Q2 to c1.6% YOY (c1.0% in Q1 2019; results due at 08:00 CET on 14 August), although the divestment of Puls makes a YOY comparison difficult. Hence, our focus will be on Accessibility (we forecast 3.5% organic growth YOY) and Patient Handling (we expect -3.0% organic growth). We see some benefits to adj. EBITA from the announced cost-saving programme. We maintain our BUY and SEK46 target price.
Underlying
Handicare Group AB

Handicare Group is a global provider of mobility solutions in the accessibility and patient handling markets measured by revenue. Co.'s objective is to operate and invest in businesses within the health and rehabilitation sector, own and manage real and personal property and conduct any business compatible therewith.

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Rune Majlund Dahl

Other Reports on these Companies
Other Reports from DnB Markets
Alexander Aukner
  • Alexander Aukner
Alexander Aukner
  • Alexander Aukner
Alexander Aukner
  • Alexander Aukner

ResearchPool Subscriptions

Get the most out of your insights

Get in touch